Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Traditional Patent Medicine ; (12): 1766-1770, 2017.
Artigo em Chinês | WPRIM | ID: wpr-661643

RESUMO

AIM To investigate the effects of Shenge Powder (Ginseng Radix et Rhizoma,Gecko) on heart function in rats with heart failure by coarctation of abdominal aorta and its mechanism of action.METHODS The heart failure rats were fed with Shenge Powder [1.89 g/(kg · d)] or bisoprolol [1 mg/(kg · d)] for twelve weeks.The pathological morphology,hemodynamics,cardiographic index and effect on protein expression of PGC-1 α in sham operation group,model group,Shenge Powder group and Bisoprolol group were observed.RESULTS Compared with the model group,Shenge Powder increased ejection fraction (EF) (P < 0.05),decreased left ventricular end-diastolic pressure (LVEDP) (P < 0.01),improved maximal rate of left ventricular pressure development (dp/dtmax) and maximal rate of left ventricular pressure decay (dp/dtmin) (P < 0.01),reduced myocardial tissue lesions and myocardial fibrosis.There was no significant difference in PGC-1α protein expression between the Shenge Powder group and the model group.CONCLUSION Shenge Powder can improve left ventricular function in rats with heart failure,and reduce the pathological changes of myocardium tissue.

2.
Chinese Traditional Patent Medicine ; (12): 1766-1770, 2017.
Artigo em Chinês | WPRIM | ID: wpr-658724

RESUMO

AIM To investigate the effects of Shenge Powder (Ginseng Radix et Rhizoma,Gecko) on heart function in rats with heart failure by coarctation of abdominal aorta and its mechanism of action.METHODS The heart failure rats were fed with Shenge Powder [1.89 g/(kg · d)] or bisoprolol [1 mg/(kg · d)] for twelve weeks.The pathological morphology,hemodynamics,cardiographic index and effect on protein expression of PGC-1 α in sham operation group,model group,Shenge Powder group and Bisoprolol group were observed.RESULTS Compared with the model group,Shenge Powder increased ejection fraction (EF) (P < 0.05),decreased left ventricular end-diastolic pressure (LVEDP) (P < 0.01),improved maximal rate of left ventricular pressure development (dp/dtmax) and maximal rate of left ventricular pressure decay (dp/dtmin) (P < 0.01),reduced myocardial tissue lesions and myocardial fibrosis.There was no significant difference in PGC-1α protein expression between the Shenge Powder group and the model group.CONCLUSION Shenge Powder can improve left ventricular function in rats with heart failure,and reduce the pathological changes of myocardium tissue.

3.
Chinese Journal of Cardiology ; (12): 995-997, 2005.
Artigo em Chinês | WPRIM | ID: wpr-253024

RESUMO

<p><b>OBJECTIVE</b>To investigate the effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure (CHF).</p><p><b>METHODS</b>Fifty-seven patients with CHF were divided into two groups randomly: received conventional treatment alone or combined with carvedilol for 8 weeks, respectively. Urine magnesium excretion (UME), plasma levels of magnesium (PMC), norepinephrine (NE), angiotensin-II (Ang-II), aldosterone (ALD), plasma renin activity (PRA) and peripheral monocyte magnesium content (MMC) were measured before and after treatments. Twenty-six health persons were selected as normal subjects.</p><p><b>RESULTS</b>There was a significant increase in UME and plasma concentrations of NE, ALD, Ang-II and PRA, and a significant decrease in MMC in patients with CHF, compared with the control group (P < 0.01). UME was positively correlated with ALD, Ang-II, PRA r = 0.41, 0.42, 0.38, respectively (P < 0.01). These parameters significantly improved after carvedilol (P < 0.05).</p><p><b>CONCLUSION</b>Carvedilol decreases significantly plasma concentrations of neurohormone and urine magnesium excretion, and increases cell magnesium content in patients with CHF.</p>


Assuntos
Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Antagonistas Adrenérgicos beta , Usos Terapêuticos , Aldosterona , Sangue , Angiotensina II , Sangue , Carbazóis , Usos Terapêuticos , Insuficiência Cardíaca , Sangue , Tratamento Farmacológico , Magnésio , Sangue , Peptídeo Natriurético Encefálico , Sangue , Norepinefrina , Sangue , Propanolaminas , Usos Terapêuticos
4.
Chinese Journal of Applied Physiology ; (6): 227-229, 2003.
Artigo em Chinês | WPRIM | ID: wpr-339630

RESUMO

<p><b>AIM</b>To study the effects of hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) on proliferation and migration of bovine coronary artery endothelial cells (BCAEC) in vitro.</p><p><b>METHODS</b>BCAECs were isolated and cultured in vitro, and divided into control group, VEGF group and HGF group. BCACEs proliferation were measured using MTT, and their migration was observed using reverse microscope.</p><p><b>RESULTS</b>The OD value of control, VEGF and HGF group were 0.22 +/- 0.01, 0.40 +/- 0.14, 0.44 +/- 0.15 respectively. The proliferation ratio of BCAECs in VEGF and HGF group was 81.8% +/- 16.9%, 100.0% +/- 21.1% respectively. There was no migration in control group, but significant migration in VEGF and HGF group.</p><p><b>CONCLUSION</b>Both VEGF and HGF can promote proliferation and migration of BCAECs, the effect of HGF is stronger than VEGF.</p>


Assuntos
Animais , Bovinos , Divisão Celular , Movimento Celular , Proliferação de Células , Células Cultivadas , Vasos Coronários , Biologia Celular , Meios de Cultivo Condicionados , Células Endoteliais , Endotélio Vascular , Biologia Celular , Fator de Crescimento de Hepatócito , Farmacologia , Fator A de Crescimento do Endotélio Vascular , Farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA